FDA Approves JAK Inhibitor Deuruxolitinib for Alopecia Areata - Medscape

Retrieved on: 2024-07-26 14:56:53

Tags for this article:

Hair diseases

Human hair

Janus kinase inhibitor

Placebo

Management of hair loss

Tofacitinib

u.s. food and drug administration

Sun Pharma

Click the tags to see associated articles and topics

FDA Approves JAK Inhibitor Deuruxolitinib for Alopecia Areata - Medscape. View article details on hiswai:

Excerpt

Study participants had at least 50% scalp hair loss as measured by Severity of Alopecia Tool (SALT) for more than 6 months. Data were also collected ...

Article found on: www.medscape.com

View Original Article